Leprosy Mailing List – March 8th, 2011
Ref.: Infolep choice of new (e-)publications on leprosy 2011 02 21
From: Erlings J., Amsterdam , Netherlands
Dear Dr Noto,
Greetings from Infolep! Below you will find a selection of new publications on leprosy. Please contact me for full text versions. Do you have publications on leprosy to share? Please let me know!
With kind regards,
Jiske Erlings
Jiske Erlings
INFOLEP
Articles |
1: Antunes SL, Medeiros MF, Corte-Real S, Jardim MR, da Nery JC, Hacker MA, et al.Microfasciculation: a morphological pattern in leprosy nerve damage. Histopathology. 2011;58(2):304-11.
2: Awofeso N.
Leprosy control, public health paradigms and stigma. Aust N Z J Public Health. 2011;35(1):9-11.
Free full text online: http://onlinelibrary.wiley.com/doi/10.1111/j.1753-6405.2010.00662.x/pdf
3: Falus O.
[Leprosy - a stigmata in the 21st century.]. Orvosi hetilap. 2011;152(7):246-51. (Hungarian).
3: Falus O.
[Leprosy - a stigmata in the 21st century.]. Orvosi hetilap. 2011;152(7):246-51. (Hungarian).
4: Iwata M.
[Clinical Aspects of Leprous Neuropathy.]. Brain and nerve = Shinkei kenkyu no shinpo. 2011;63(2):157-64. (Japanese).
5: Kai M, Nguyen Phuc NH, Nguyen HA, Pham TH, Nguyen KH, Miyamoto Y, et al.
Analysis of drug-resistant strains of mycobacterium leprae in an endemic area of Vietnam. Clin Infect Dis. 2011;52(5):e127-32.
Free full text online: http://cid.oxfordjournals.org/content/52/5/e127.full.pdf+html
6: Luna IT, Beserra EP, Alves MD, da Pinheiro PN.
[Adhesion to Leprosy treatment: inherent difficulties of the patients.]. Revista brasileira de enfermagem. 2010;63(6):983-90. (Portuguese).
Free full text online: http://www.scielo.br/pdf/reben/v63n6/18.pdf
7: Mastrangelo G, da Neto JS, da Silva GV, Scoizzato L, Fadda E, Dallapicol M.
Leprosy reactions: the effect of gender and household contacts. Mem Inst Oswaldo Cruz. 2011;106(1):92-96.
Free full text online: http://memorias.ioc.fiocruz.br/106(1)/106_1_2272.pdf
8: Matsuo C, Talhari C, Nogueira L, Rabelo RF, Santos MN, Talhari S.
[Borderline lepromatous leprosy.]. Anais brasileiros de dermatologia. 2010;85(6):921-2. (Portuguese)
[Borderline lepromatous leprosy.]. Anais brasileiros de dermatologia. 2010;85(6):921-2. (Portuguese)
9: Ofosu AA, Bonsu G.
Case control study to determine the factors associated with leprosy in the sene district, brong ahafo region of
Free full text online:http://www.ghanamedj.org/articles/September2010/Final%20Leprosy%20case%20control%20study.pdf
10: Proto RS, Machado Filho CD, Rehder JR, Paixão MP, Angelucci RI.[Quality of life in leprosy: a comparative analysis between patients in the Amazon region and patients in Santo André in the ABC region of São Paulo , Brazil. ].Anais brasileiros de dermatologia. 2010;85(6):939-41. (Portuguese)
Free full text online: http://www.scielo.br/pdf/abd/v85n6/en_v85n6a30.pdf
11: Rada E, Aranzazu N, Rodríguez V, Borges R, Convit J.[Serological and cellular reactivity to mycobacterial proteins in Hansen's disease]. Invest Clin. 2010;51(3):325-40. (Spanish)
Free full text online: http://www.scielo.org.ve/pdf/ic/v51n3/art04.pdf
Free full text online: http://www.scielo.br/pdf/abd/v85n6/en_v85n6a30.pdf
11: Rada E, Aranzazu N, Rodríguez V, Borges R, Convit J.[Serological and cellular reactivity to mycobacterial proteins in Hansen's disease]. Invest Clin. 2010;51(3):325-40. (Spanish)
Free full text online: http://www.scielo.org.ve/pdf/ic/v51n3/art04.pdf
12: Rodrigues MM, de Ximenes RA, da Dantas MM, Batista TD, de Freire AL.[UVB susceptibility as a risk factor to the development of lepromatous leprosy.]. Anais brasileiros de dermatologia. 2010;85(6):839-42. (Portuguese)
Free full text online: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962010000600009&lng=en&nrm=iso&tlng=en
Other Publication(s) |
Moran M, Guzman G, Henderson K, Abela-Oversteegen
L. G-finder 2010: Neglected disease research and development: is the global financial crisis changing R&D?.Sydney ; London : Policy Cures; 2011.
L. G-finder 2010: Neglected disease research and development: is the global financial crisis changing R&D?.
No comments:
Post a Comment